BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2000
View Archived Issues
Preclinical study shows FGF-4 gene therapy increases cardiac function in setting of heart failure
Read More
Phase I/II clinical trial data reported for MTC-DOX in liver cancer
Read More
Optison to enter pivotal clinical trials in Japan for second indication
Read More
RHeoGene updates gene-switching development program at BIO 2000
Read More
AngioMARK shows promise for diagnosis, management of muscular dystrophy
Read More
UroGen awarded SBIR grant to support prostate cancer gene therapy product development
Read More
Regeneron commences phase II Axokine trial for treatment of obesity
Read More
Nortran begins phase II trial of CP1 for chronic idiopathic cough
Read More
Safety and tolerability of phenserine confirmed in phase I clinical trial
Read More
Breast cancer trial of annamycin commenced by Aronex
Read More
Cell Therapeutics submits NDA for arsenic trioxide
Read More
Draxis seeks approval of Levulan PDT in Canada
Read More
New Toyama compounds useful for influenza virus infections
Read More
Pola presents new antifungal products
Read More
Diarylbenzopyran derivatives designed at Pacific for inflammation, pain and fever
Read More
Recent Japanese patent covers Arax's new antiulcer agents
Read More
Orally effective GH secretagogues claimed by Sumitomo
Read More
Inhibitors of Lp-PLA2 with pyrimidinone structure claimed by SB for atherosclerosis
Read More
Potentially safer antimigraine agents presented at ACS meeting by Canadian company
Read More
A-228839: synthesis of a new agent for blocking Ras function
Read More
DuPont identifies potent, orally active CRF antagonist
Read More
Health Canada approves Avandia for treatment of type II diabetes
Read More
Meperidine analogues under study as dopamine uptake inhibitors by NIDA and collaborators
Read More
European Commission approves Monsanto/Pharmacia & Upjohn merger
Read More
Multiple mechanisms of action proposed for beneficial cardiac effects of HNS-32
Read More
K(ATP) channel opener YM-934 protects cardiac mitochondrial and functional activity during ischemia
Read More
Natural and synthetic neurotrophic factor secretion enhancers under study in Japan
Read More
Cardioprotective effects of TAK-044 in isolated perfused rat hearts
Read More